Method of differentially diagnosing different types of dementia

US9028802B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9028802-B2
Application numberUS-201213683022-A
CountryUS
Kind codeB2
Filing dateNov 21, 2012
Priority dateSep 26, 2007
Publication dateMay 12, 2015
Grant dateMay 12, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method of differentially diagnosing different types of dementia. In particular, the method relates to the use of specific SPECT tracers for differentially diagnosing Alzheimer's disease, Lewy-Body Dementia, and Frontotemporal Dementia.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of data acquisition for diagnosing and differentiating between different types of dementia, said method comprising: administering at least one compound which is suitable for SPECT, which crosses a blood brain barrier and which is associated with a Dopamine Transporter (DAT) to a human or animal being, said at least one compound selected from the group consisting of Technepine, Fluoratec, TRECTEC-1, TRODAT-1, Altropane®, Dopascan, and DaTSCAN;…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9028802B2 cover?
The present invention relates to a method of differentially diagnosing different types of dementia. In particular, the method relates to the use of specific SPECT tracers for differentially diagnosing Alzheimer's disease, Lewy-Body Dementia, and Frontotemporal Dementia.
Who is the assignee on this patent?
Koninkl Philips Electronics Nv, Koninkl Philips Nv
What technology area does this patent fall under?
Primary CPC classification A61K51/0448. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).